Skip to main content
logo
Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,845.20
-45.95 (-2.43%)
At close: May 22, 2026

BOM:524715 Revenue

In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 604.34B INR with 14.94% growth. Sun Pharmaceutical Industries had revenue of 150.70B in the quarter ending March 31, 2026, with 16.29% growth.

Revenue
604.34B
Revenue Growth
+14.94%
P/S Ratio
7.99
Revenue / Employee
13.21M
Employees
43,000
Market Cap
4.54T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026604.34B78.55B14.94%
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Larsen & Toubro2.92T
Hindalco Industries2.62T
Tata Steel2.32T
JSW Steel1.85T
Adani Enterprises1.00T
Titan Company875.84B
Axis Bank745.20B
Kotak Mahindra Bank740.43B
Revenue Rankings

Sun Pharmaceutical Industries News

More News